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Summary.-Transplant immunity to adenovirus 12-induced tumour cells was
demonstrated in CBA mice which had been previously immunized with extracts of
homologous tumour cells. Immunization of mice with tumour cell extract together
with heat-killed Mycobacterium butyricum gave better transplant immunity to
tumour cell challenge than tumour extracts alone. Mice immunized with Myco-
bacterium butyricum alone prior to challenge with tumour cells, did not show any
significant difference in the incidence of tumours from control mice.
PREVIOIUS studies have shown that
animals immunized with Mycobacterium
bovis (BCG strain), Corynebacterium
parvum or Bordetella pertu,ssis were re-
latively resistant to transplanted tumours
(Old, Clarke and Benacerrof, 1959; Fisher,
Grace and Mannick, 1970; Malkiel and
Hargis, 1961). Non-specific enhancement
of transplantation immunity can also be
achieved by immunizing with methanolic
extracts of BCG (Weiss, Bonhag and
De'Ome, 1961; Weiss, Bonhag and Leslie,
1966). The present study reports the
incidence of tumours in CBA mice inocu-
lated with adenovirus 12-induced tumour
cells following immunization with heat-
killed Mycobacterium butyricum alone and
in conjunction with cell-free homologous
tumour extracts.
MATERIALS AND METHODS
Tumour cells and tumour extracts
Tumour cell suspensions were prepared
from an adenovirus 12-induced transplantable
CBA mouse tumour as described previously
(Potter and Oxford, 1970); and cells sus-
pended at a concentration of 5-0 x 106
viable cells/ml in Eagle's minimal essential
medium (2 / inactivated calfserum). Tumour
cell extracts were prepared from 200% (v/v)
transplantable tumour cells which were
homogenized, centrifuged at 100,000 g for
1 hour, and filtered to remove whole cells
(Potter and Oxford, 1970).
Mycobacterium butyricum
Mycobacteriunt butyricum (Myco. buty-
ricum), grown on solid agar, was suspended in
PBS (10o% v/v) and heat-killed by autoclaving
(10 lb/10 min) and dried over phosphorous
pentoxide. The organism was then ground
up and resuspended in PBS at a concentration
of 0 5 mg/ml.
Experimental design
Groups of approximately 20 CBA mice
were inoculated with either 0-1 ml of tumour
extract, 0-1 ml of tumour extract mixed with
0-1 ml of Myco. butyricum, 0-1 ml Myco.
butyricum alone or PBS (control) at weekly
intervals for 3 weeks. Each animal received
0-2 ml volumes of inoculum subcutaneously,
and where only one reagent was given, the
volumes were made up to 0-2 ml with PBS.
Two weeks following the third inoculation
each mouse was inoculated with 5 x 105
viable tumour cells in an 0-1 ml volume.
Mice were examined weekly for 5 weeks for
tumours, and mice bearing tumours greater
than 15 mm diameter were killed.140 R. C. REES AND C. W. POTTER
TABLE I. Incidence of Tumours in Mice Immunized with Tumour Cell Extracts and
Myco. butyricum and Subsequently Challenged with 5'0 x 105 Tumour Cells
Incidence of tumours (weeks)
Mice immunized Total
with 1 2 3 4 5 °/
Tumour extract . 0/16 0/16 4/16 7/16 7/16 . 44
Tumour extract + 0/18 0/18 0/18 0/18 1/18 . 5-5
Myco. butyricum
Myco. butyricum . 0/17 6/17 14/17 16/17 17/17 . 100
- 0/18 2/18 12/18 13/18 14/18 78
RESULTS
The incidence of tumours in mice
immunized with extracts from adenovirus
12-induced tumour cells or extracts with
Myco. butyricum, and subsequently chal-
lenged with 5 x 105 live tumour cells is
shown in Table I. The incidence of
tUmours in mice immunized with extracts
from adenovirus 12-induced tumour cells
was significantly less than that observed
in control mice (P = <0 05). In addition,
the incidence of tumours in mice immu-
nized with tumour extract together with
Myco. butyricum was significantly less
than that seen in mice immunized with
tumour extracts alone (P = <005). More
tumours were recorded for mice inoculated
with Myco. butyricum alone prior to
challenge with tumour cells, than for
control animals, but this difference was
not statistically different.
DISCUSSION
The results presented indicate that
CBA mice immunized with extracts of
tumour cells were relatively immune to
subsequent challenge ofviable homologous
tumour cells. This transplant immunity,
which has been reported previously from
this laboratory (Potter and Oxford, 1970;
Brown, Potter and Oxford, 1971), was
significantly greater in mice previously
immunized with tumour cell extracts
together with killed Myco. butyricum.
Immunization with tumour cells together
with Myco. bovis (BCG strain) has been
shown to increase transplantation im-
munity; the bacteria were shown to
enhance the cellular immune response to
tumour cell antigens (Zbar et al., 1971).
The present results may be due to the
same mechanism; however, our findings
were for dead Myco. butyricum as com-
pared with live BCG. Non-specific im-
munity, induced with methanolic extracts
of BCG, has been reported (Weiss et al.,
1966), but killed Myco. butyricum alone
did not give tumour immunity in our
system.
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